Intraocular Tissue Distribution of Betamethasone after Intrascleral Administration Using a Non-biodegradable Sustained Drug Delivery Device
Open Access
- 1 June 2003
- journal article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 44 (6) , 2702-2707
- https://doi.org/10.1167/iovs.02-0956
Abstract
Purpose. To evaluate the tissue distribution of betamethasone (BM) after implantation of a nonbiodegradable intrascleral implant as a new, controlled intraocular delivery system.Keywords
This publication has 0 references indexed in Scilit: